First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas
Patnaik, A., Appleman, L.J., Tolcher, A.W., Papadopoulos, K.P., Beeram, M., Rasco, D.W., Weiss, G.J., Sachdev, J.C., Chadha, M., Fulk, M., Ejadi, S., Mountz, J.M., Lotze, M.T., Toledo, F.G.S., Chu, E., Jeffers, M., Peña, C., Xia, C., Reif, S., Genvresse, I., Ramanathan, R.K.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Safety and efficacy of quavonlimab, a novel anti-CTLA-4 antibody (MK-1308), in combination with pembrolizumab in first-line advanced non-small-cell lung cancer
Perets, R., Bar, J., Rasco, D.W., Ahn, M.-J., Yoh, K., Kim, D.-W., Nagrial, A., Satouchi, M., Lee, D.H., Spigel, D.R., Kotasek, D., Gutierrez, M., Niu, J., Siddiqi, S., Li, X., Cyrus, J., Chackerian, A., Chain, A., Altura, R.A., Cho, B.C.
Published in Annals of oncology (01.03.2021)
Published in Annals of oncology (01.03.2021)
Get full text
Journal Article
A Phase 1 study of ARQ 087, an oral pan-FGFR inhibitor in patients with advanced solid tumours
Papadopoulos, K P, El-Rayes, B F, Tolcher, A W, Patnaik, A, Rasco, D W, Harvey, R D, LoRusso, P M, Sachdev, J C, Abbadessa, G, Savage, R E, Hall, T, Schwartz, B, Wang, Y, Kazakin, J, Shaib, W L
Published in British journal of cancer (21.11.2017)
Published in British journal of cancer (21.11.2017)
Get full text
Journal Article
Updated Findings and Biomarker Analysis From the Ongoing Phase 1 Study of Enhancer of Zeste Homolog 2 (EZH2) Inhibitor CPI-0209 in Patients With Advanced Solid Tumors
Papadopoulos, K.P., Gutierrez, M., Duska, L.R., Gandhi, L., Bommi-Reddy, A., Adams, E., Jauch-Lembach, J., Rasco, D.W.
Published in European journal of cancer (1990) (01.10.2022)
Published in European journal of cancer (1990) (01.10.2022)
Get full text
Journal Article
438OMETEOR-1: A phase I study of GSK3326595, a first-in-class protein arginine methyltransferase 5 (PRMT5) inhibitor, in advanced solid tumours
Siu, L L, Rasco, D W, Vinay, S Postel, Romano, P Martin, Menis, J, Opdam, F L, Heinhuis, K M, Egger, J L, Gorman, S A, Parasrampuria, R, Wang, K, Kremer, B E, Gounder, M M
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
457PFirst-in-human study of ABBV-621 in patients (pts) with previously treated sold tumours: Dose-optimization cohorts
Calvo, E, de Jonge, M J A, Rasco, D W, Moreno, V, Chang, Y -W, Chiney, M, Motwani, M, Penugonda, S, Petrich, A M, Ratain, M J, LoRusso, P
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1187PDPhase II study of lenvatinib plus pembrolizumab for disease progression after PD-1/PD-L1 immune checkpoint inhibitor in metastatic clear cell renal cell carcinoma (mccRCC): Results of an interim analysis
Lee, C-H, Shah, A Y, Makker, V, Taylor, M H, Shaffer, D, Hsieh, J J, Cohn, A L, DiSimone, C, Marin, A Pinto, Rasco, D W, Ribe, S G, Richards, D A, Stepan, D E, Dutcus, C E, Wu, J, Schmidt, E V, Perini, R F, Motzer, R J
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Use of chemotherapy for advanced non-small cell lung cancer in a contemporary and diverse patient population
Rasco, D. W., Yan, J., Dowell, J., Gerber, D. E.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
Phase I trial of the first-in-class EGFR antibody mixture, Sym004, in patients with advanced solid tumors
Dienstmann, R., Tolcher, A. W., Papadopoulos, K. P., Rasco, D. W., Tabernero, J., Brana, I., Piera, A., Skartved, N. J., Aladdin, H., Petersen, J., Patnaik, A.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Consenting factors in clinical cancer research: Observations from a cancer center tissue repository
Gerber, D. E., Rasco, D. W., Skinner, C. S., Dowell, J., Yan, J., Sayne, J. R., Xie, Y.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
A phase I, open-label, dose-escalation study of the novel oral proteasome inhibitor (PI) ONX 0912 in patients with advanced refractory or recurrent solid tumors
Papadopoulos, K. P., Mendelson, D. S., Tolcher, A. W., Patnaik, A., Burris, H. A., Rasco, D. W., Bendell, J. C., Gordon, M. S., Kato, G., Wong, H., Bomba, D., Lee, S., Gillenwater, H. H., Woo, T., Infante, J. R.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
The clinical effect of the dual-targeting strategy involving PI3K/AKT/mTOR and RAS/MEK/ERK pathways in first-in-human phase I study: The START Center experience
Shimizu, T., Tolcher, A. W., Papadopoulos, K. P., Beeram, M., Rasco, D. W., Smith, L. S., Gunn, S., Smetzer, L., Mays, T. A., Kaiser, B., Alvarez, C., Mangold, G. L., Patnaik, A.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Attitudes toward clinical research: an analysis of 922 patients in a university-based tissue repository
Rasco, D. W., Xie, Y., Yan, J., Sayne, J. R., Gerber, D. E.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
Determination of the maximum tolerated dose (MTD) of MGCD265, an oral Met/VEGFR multitargeted receptor tyrosine kinase inhibitor, in combination with docetaxel
Rasco, D. W., Patnaik, A., Amaravadi, R. K., Papadopoulos, K. P., Haas, N. B., Tolcher, A. W., Beeram, M., Harlacker, K., Drouin, M. A., Tawashi, M., Wang, J., Karam, A., Maroun, C. R., Bonfils, C., Mehran, M., Besterman, J. M., O'Dwyer, P. J.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article